On February 20, Roche Group and Zhuhai People's Hospital Medical Group formally signed a strategic cooperation agreement.

Spectrum Solutions announced the U.S. Food and Drug Administration (FDA) has granted 510(k) Class II clearance to the SDNA Saliva Collection Device as a microbial nucleic acid storage and stabilization device.

Veracyte, Inc. (Nasdaq: VCYT) announced financial results for the fourth quarter and full year ended December 31, 2022.

On 18 February, a launch ceremony was held in Macau for Macau Biotech Company jointly established by Namyue Group and Shenzhen Yhlo Biotech Co., Ltd.

Sherlock Biosciences said that the U.S. Patent and Trademark Office (USPTO) has granted a patent for the diagnostic use of the Cas12 enzyme, an integral part of the firm's diagnostic testing technology.

Becton Dickinson announced that its BD Onclarity human papillomavirus virus test has been approved by the US Food and Drug Administration for use with the Hologic ThinPrep Pap test.

On February 19, 2023, Abbott, a leading medical and health company in the world, signed a strategic cooperation memorandum with China Medical Devices Co., Ltd., a highly specialized medical device industry chain platform in China, which is affiliated to Sinopharm Holdings.

Global talent leader WilsonHCG has published its annual Fortune 100 Employment Branding Report.

OraSure Technologies, Inc., a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced its financial results for the three months ended December 31, 2022.

After issuing emergency use authorizations for more than 400 COVID-19 tests, the U.S. Food and Drug Administration said Wednesday that it is ending its EUA review of new in vitro diagnostics.

UK digital diagnostics firm EDX Medical Group said Friday that it is acquiring in vitro diagnostics and immunochemistry firm Torax Biosciences.

Labcorp, a leading global life sciences company, today announced results for the fourth quarter and year ended Dec. 31, 2022, full-year 2023 guidance.

Recently, Chongqing Federation of Industry and Commerce released the "Top 100 list of Chongqing Private Enterprises' Science and Technology Innovation Index", and Zybio ranked 3rd on the list.

After issuing Emergency Use Authorizations for more than 400 COVID-19 tests and seven Mpox tests, the US Food and Drug Administration said Wednesday that it is nearing the end of EUA reviews of new in vitro diagnostics.

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, today announced financial results for the fourth quarter and full year ended December 31, 2022.